Subcutaneous vs IM Testosterone Injections for Men: What’s the Difference?
If you are considering testosterone therapy, one of the first practical questions is how the medication should be given. For most men using injectable testosterone, the two main options are intramuscular (IM) and subcutaneous (SubQ) injections. Both routes can work well. The better choice often comes down to comfort, convenience, side effects, and how your body responds over time.
Current research suggests that subcutaneous testosterone can achieve therapeutic serum testosterone levels comparable to intramuscular injections in many patients, while often being easier to self-administer. At the same time, IM remains the more traditional route and is still widely used in clinical practice.
At Enhanced Metabolics, this is not just a technical detail. It is a shared decision between provider and patient. The route of administration can affect adherence, comfort, and how easy it is to stay consistent with treatment over time.
What does intramuscular testosterone mean?
An intramuscular injection places testosterone into the muscle, usually the glute, thigh, or sometimes the deltoid. This has been the standard route for injectable testosterone for many years and remains widely used because of its long clinical track record.
Potential advantages of IM injections
IM injections are familiar, standard, and widely available. Many clinicians are comfortable prescribing and monitoring them, and many patients have used them successfully for years. In some men, IM simply fits their routine and works well enough that there is no convincing reason to change.
Potential downsides of IM injections
IM injections often require a longer needle and may feel more intimidating or less comfortable for self-administration. Larger IM doses spaced farther apart may also create bigger peak-and-trough swings in testosterone levels, depending on the dosing schedule. Those swings can matter if a patient feels very different at the beginning versus the end of the injection interval.
What does subcutaneous testosterone mean?
A subcutaneous injection places testosterone into the fatty tissue just under the skin, usually in the abdomen or thigh. Although this route was once considered unconventional for injectable testosterone, multiple published studies and reviews now support the SubQ route as an effective and practical option.
Potential advantages of SubQ injections
SubQ injections usually use a smaller needle and are often easier to self-administer. Many patients find them less intimidating and more comfortable, which can improve adherence with treatment. Since testosterone therapy works best when the dosing schedule is followed reliably, this can be a meaningful advantage. Published studies also show that many patients tolerate the SubQ route well and often prefer it.
Some clinicians also favor SubQ injections because the subcutaneous tissue is less vascular than muscle, which may support a steadier absorption profile in some dosing protocols. In practice, many men report that smaller, more frequent SubQ injections feel smoother over time than larger, less frequent IM injections.
Potential downsides of SubQ injections
SubQ injections can still cause local irritation, redness, itching, or swelling in some patients. They are not automatically better for everyone. Some men simply prefer IM or feel more comfortable staying with the traditional route because of its proven track record. It is also important to note that using the SubQ route does not remove the need for proper monitoring of testosterone levels, estradiol, CBC, and clinical response.
Are testosterone blood levels different with SubQ vs IM injections?
This is one of the most common questions men ask, and the current answer is no, not in a clinically significant way when the dosing and injection intervals are appropriate.
A pharmacokinetic study comparing subcutaneous and intramuscular testosterone undecanoate found that testosterone, dihydrotestosterone, and estradiol levels did not differ substantially between routes, suggesting that the SubQ route can be a viable alternative without requiring a route-based dose change by default.
Another important study found that men receiving weekly subcutaneous testosterone cypionate maintained stable total and free testosterone concentrations between injections, supporting the idea that SubQ dosing can provide steady therapeutic exposure.
A 2021 review of SubQ testosterone therapy concluded that the route can achieve serum concentrations comparable to IM administration while also being safe, practical, and often better accepted by patients.
More recently, a 2023 prospective comparison study directly compared SubQ and IM testosterone and evaluated biochemical changes, clinical effects, and quality of life. This kind of head-to-head research helps strengthen the argument that SubQ is not just convenient, but clinically legitimate.
So is one route better?
Not universally.
For some men, IM is still the better fit. For others, SubQ is clearly easier and more sustainable. In real-world practice, the best route is usually the one that:
reliably achieves therapeutic testosterone levels
is well tolerated
is easy to repeat consistently
fits the patient’s comfort level and lifestyle
What this means for men considering TRT
For many men, the practical question is not “Which route is theoretically best?” It is “Which route can I stay consistent with, tolerate well, and monitor safely?”
The available evidence supports both IM and SubQ testosterone as valid options. For men who want a smaller needle, easier self-administration, or potentially steadier-feeling dosing, SubQ may offer a real advantage. For men already doing well with IM, there may be no reason to change.
The route should be chosen in the context of the whole treatment plan, including symptoms, lab response, hematocrit, estradiol trends, and the realities of long-term adherence.
Conclusion
Subcutaneous and intramuscular testosterone injections can both be effective. Current evidence suggests that SubQ testosterone can produce serum testosterone levels that are broadly comparable to IM injections, while often being easier for patients to administer and tolerate. IM remains a strong option with a long track record, and for some men it is still the best fit. The right choice depends on comfort, consistency, lab response, and how the patient feels over time.
If you are considering testosterone therapy or want to discuss which injection route may fit you best, the next step is a personalized plan based on your goals, labs, and treatment preferences.
Enhanced Metabolics provides men’s health telemedicine for patients in Arizona and Florida, with a focus on hormone optimization, performance, and long-term health. Book a consult to discuss which testosterone route may be the best fit for you.
Enhanced Metabolics provides clinician-guided testosterone optimization for men in Arizona and Florida. Book a consult to discuss whether subcutaneous or intramuscular testosterone is the better fit for your goals, comfort, and long-term treatment plan.
FAQs
Is subcutaneous testosterone as effective as intramuscular testosterone?
Current studies suggest that subcutaneous testosterone can achieve therapeutic testosterone levels comparable to intramuscular injections in many patients.
Does SubQ testosterone give lower lab levels than IM?
No. Published pharmacokinetic work suggests that testosterone levels may be broadly similar when the dose and frequency are appropriate.
Is SubQ testosterone less painful?
For many men, yes. SubQ injections often use smaller needles and are easier to self-administer, although some patients experience local skin irritation.
Is IM testosterone still a good option?
Yes. IM testosterone remains a standard and effective route, especially for men who tolerate it well and prefer the traditional approach.
References
Figueiredo MG, Spratt DI. Testosterone therapy with subcutaneous injections: a safe, practical, and reasonable option. Transl Androl Urol. 2022;11(4):558-566. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9006970/
Turner L, Ly LP, Desai R, et al. Pharmacokinetics and acceptability of subcutaneous injection of testosterone undecanoate. J Endocr Soc. 2019. Available at: https://academic.oup.com/jes/article/3/8/1531/5523891
Spratt DI, Stewart II, Savage C, et al. Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: demonstration in female-to-male transgender patients. J Clin Endocrinol Metab. 2017;102(7):2349-2355. Available at: https://academic.oup.com/jcem/article/102/7/2349/3098651
Wilson SK, Kohn TP, Pastuszak AW. A prospective comparison study of subcutaneous and intramuscular testosterone injections: biochemical changes, clinical effects, and quality of life. J Urol. 2023. Available at: https://pubmed.ncbi.nlm.nih.gov/37788646/
American Urological Association. Testosterone Deficiency Guideline. Available at: https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
Pastuszak AW, Gomez LP, Scovell JM, et al. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age. Sex Med Rev. 2022. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9293229/
McFarland J, Craig W, Clarke NJ, Spratt DI. Serum testosterone concentrations remain stable between injections in patients receiving subcutaneous testosterone. Sex Med. 2017. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5686655/
Educational disclaimer
This blog is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The information provided should not be considered medical advice and should not replace individualized evaluation, diagnosis, or treatment from a licensed healthcare professional. Testosterone therapy should only be started, adjusted, or discontinued under the supervision of a qualified clinician, with appropriate monitoring based on the patient’s symptoms, history, and lab results.